Sprott Inc’s Amgen AMGN Stock Holding History

Sprott Inc’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-15,000	Closed	-$3.04K	–	104
2020 Q1	$3.04K	Hold	15,000	–	–	0.11%	46
2019 Q4	$3.62K	Buy	15,000 +10,000	+200%	+$2.2M	0.06%	45
2019 Q3	$968K	Hold	5,000	–	–	0.25%	59
2019 Q2	$921K	Hold	5,000	–	–	0.22%	61
2019 Q1	$949	Sell	5,000 -5,000	-50%	-$955K	0.21%	60
2018 Q4	$1.95M	Sell	10,000 -14,200	-59%	-$2.77M	0.54%	52
2018 Q3	$5.02M	Sell	24,200 -300	-1%	-$59.1K	1.25%	35
2018 Q2	$4.52M	Buy	24,500 +5,500	+29%	+$973K	0.93%	41
2018 Q1	$3.24M	Sell	19,000 -6,600	-26%	-$1.21M	0.67%	48
2017 Q4	$4.45M	Hold	25,600	–	–	1.29%	33
2017 Q3	$4.77M	Hold	25,600	–	–	1.22%	31
2017 Q2	$4.41M	Buy	+25,600	New	+$4.16M	0.16%	73

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Sprott Inc's AMGN Position: Q2 2020 in Review

Sprott Inc sold out of Amgen (AMGN) in Q2 2020, closing a stake of 15,000 shares — an estimated $3.04K sold.

Sprott Inc first reported a position in AMGN in Q2 2017 and held it in 12 quarters. The position peaked at $5.02M in Q3 2018. 2,090 funds tracked by Wall St. Rank hold AMGN as of Q2 2020.

Sprott Inc reported no remaining Amgen position as of Q2 2020 after selling out during the quarter.
Sprott Inc sold 15,000 Amgen shares in Q2 2020, an estimated $3.04K.
Sprott Inc first reported a position in Amgen in Q2 2017 and held it in 12 quarters.
Sprott Inc's Amgen position peaked at $5.02M in Q3 2018.
2,090 funds tracked by Wall St. Rank held Amgen as of Q2 2020.

Based on Sprott Inc's 13F filing for Q2 2020, filed 14 Aug 2020.